Back to Search
ERIK OFFERMAN, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1336638840IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Education
OTHER
Class of 2013
Research & Publications (10)
Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages.
PMID 17320883·Atherosclerosis·2007
7-preclinical
Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification.
PMID 17339654·J Lipid Res·2007
7-preclinical
Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
PMID 16946130·Arterioscler Thromb Vasc Biol·2006
7-preclinical
Anti-atherosclerotic effect of amlodipine, alone and in combination with atorvastatin, in APOE*3-Leiden/hCRP transgenic mice.
PMID 16424791·J Cardiovasc Pharmacol·2006
7-preclinical
Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice.
PMID 15514207·Arterioscler Thromb Vasc Biol·2005
7-preclinical
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
PMID 15920036·Arterioscler Thromb Vasc Biol·2005
7-preclinical
Absence of an atheroprotective effect of the garlic powder printanor in APOE*3-Leiden transgenic mice.
PMID 15530902·Atherosclerosis·2004
7-preclinical
Genetic deletion of tissue-type plasminogen activator (t-PA) in APOE3-Leiden mice reduces progression of cholesterol-induced atherosclerosis.
PMID 14515193·Thromb Haemost·2003
7-preclinical
Overexpression of fibrinogen in ApoE*3-Leiden transgenic mice does not influence the progression of diet-induced atherosclerosis.
PMID 12195708·Thromb Haemost·2002
7-preclinical
Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
PMID 11282910·Circulation·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 550 1ST AVE
NEW YORK, NY 10016 - Phone
- (212) 263-5506
Quick Facts
- NPI
- 1336638840
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 13
- Publications
- 10
Are you this provider?
Claim Your Profile